SPONSOR
H. Lundbeck A/S
Total Trials
4
Recruiting
4
Phases
Phase 3, Phase 1, Phase 2
Conditions studied: Chronic Migraine in ChildrenEpisodic MigraineMigraineCongenital Adrenal Hyperplasia
NCT04965675 Phase 3
Recruiting
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Chronic Migraine in Children
NCT05897320 Phase 3
Recruiting
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Episodic Migraine
NCT05164172 Phase 3
Recruiting
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Migraine
NCT05669950 Phase 1, Phase 2
Recruiting
A Trial of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia
Congenital Adrenal Hyperplasia